KDM6B and experimental autoimmune encephalomyelitis: Silencing of JMJD3 has been shown to improve the severity of rheumatoid arthritis (RA) in synovial fibroblasts and ameliorate disease severity in experimental autoimmune encephalomyelitis [27, 28].